Macrophages are prominent in hypoxic areas of atherosclerotic lesions, and their secreted proteoglycans (PG), such as versican, can modulate the retention of lipoproteins and the activity of enzymes, cytokines, and growth factors involved in atherogenesis. In this study, we report the effects of hypoxia on PG secreted by human monocyte-derived macrophages (HMDM) and the potential regulation by the transcription factor hypoxia-inducible factor (HIF-1α and HIF-2α). We found that versican co-localized with HIF-1α in macrophage-rich areas in human advanced atherosclerotic lesions. Versican and perlecan mRNA expression increased after exposure to 0.5% O 2 (hypoxia) compared with 21% O 2 (control cells). Using precursors to GAG biosynthesis combined with immunoabsorption with a versican antibody an increased versican synthesis was detected at hypoxia. Furthermore, siRNA knockdown of HIF-1α and HIF-2α in THP-1 cells showed that the hypoxic induction of versican and perlecan mRNA expression involved HIF signaling. Versican expression was co-regulated by HIF-1α and HIF-2α but expression of perlecan was influenced only by HIF-1α and not by HIF-2α knockdown. The results show that oxygen concentration is an important modulator of PG expression in macrophages. This may be a novel component of the complex role of macrophages in atherosclerosis.
Introduction
It is well known that macrophage-rich areas of advanced atherosclerotic lesions contain areas of severe hypoxia (Sluimer and Daemen 2009) where oxygen tension can be reduced from 20 to 70 mmHg (2.5-9% oxygen), the levels in healthy tissues, to below 10 mmHg (<1% oxygen) (Lewis et al. 1999) . Earlier studies have indicated that hypoxia promotes the development of lesions by altering the phenotype of the recruited macrophages as well as the inflammatory response (Rydberg et al. 2003; Bosco et al. 2008) .
A critical step in the development of atherosclerotic plaques appears to be the retention of apoB-100-containing lipoproteins in the arterial wall, mediated by the interaction between positively charged regions of apoB-100 and the negatively charged glycosaminoglycan (GAG) chains of proteoglycans (PG) in the intima (Camejo et al. 1998; Gustafsson et al. 2004; Tannock and Chait 2004; Tabas et al. 2007 ). The retained lipoproteins are susceptible to modification and uptake by resident macrophages, leading to an inflammatory response and the formation of lipidloaded macrophages, or foam cells (Williams and Tabas 1995; Steinberg 2002) .
The PG versican, with high capacity to bind lipoproteins, cytokines, and enzymes because of its large number of GAG chains Khalil et al. 2004) , is abundant in the extracellular matrix of human lesions (Llorente-Cortes et al. 2002; Wight and Merrilees 2004; Kenagy et al. 2006) . Although smooth muscle cells (SMC) appear to be the main producers of versican in the intima, macrophages have been shown to synthesize versican and other PG including perlecan, serglycin, and macrophage colony stimulating factor (MCSF) (Chang et al. 1998; Kulseth et al. 1998; Makatsori et al. 2003) . Furthermore, recent results suggest that macrophages may play an important role in versican accumulation in lesions (Seidelmann et al. 2008) . To date, little has been published about the effect of hypoxia on PG synthesis by macrophages. However, we recently reported that human macrophages exposed to hypoxia have decreased synthesis of the cell-associated heparan sulfate PG syndecan (Asplund et al. 2009) .
In this study, we analyzed the co-localization of macrophages, versican, and HIF-1α in human atherosclerotic lesions and assessed the effects of hypoxia on secreted PG expression and synthesis using human monocyte-derived macrophages (HMDM) and the monocyte cell line THP-1. We also investigated the mechanism behind the effects of hypoxia on PG production from macrophages and showed a role for the hypoxia-inducible factors HIF-1α and HIF-2α, the main regulators of the cellular response to oxygen deprivation.
Results

Co-localization of versican and HIF-1α in macrophage-rich areas in human advanced lesions
We used immunohistochemistry to stain serial sections of human carotid lesions and observed CD68-positive macrophages that did not co-localize with the smooth muscle-specific α-actin ( Figure 1A and B). We also observed that versican and HIF-1α co-localized and were present in the CD68-positive macrophage areas ( Figure 1C-F) .
Hypoxia increases versican and perlecan expression in HMDM
The effects of different oxygen concentrations and time of incubation on PG mRNA expression in HMDM were studied. Immunoreactivity of versican and HIF-1α in CD68-positive macrophage-rich areas of human carotid lesions. Serial sections stained for CD68 (A), smooth muscle-specific α-actin (B), versican (C), and HIF-1α (D). Co-localization of versican (E) and HIF-1α (F) in a CD68-positive macrophage area is shown by high magnification of (C) and (D), respectively. Serial sections from one representative donor out of three are shown.
We observed that mRNA expression levels of both versican and perlecan increased sharply at 0.5% oxygen, and maximum expression was achieved after 24 h incubation in 0.5% oxygen (Figure 2A-D) . Because we observed a reduction in versican mRNA expression in 21% oxygen after 12 h incubation (Figure 2C) , we repeated this experiment in the presence of serum and observed stable versican expression over time under these conditions (data not shown).
The viability of HMDM after hypoxic incubation was measured by the trypan blue exclusion test and we found no changes in cell viability after 24 h exposure to 0.5% oxygen compared with 21% oxygen (supplemental data figure 1). Based on these results, we chose to use 0.5% oxygen for 24 h in hypoxia experiments and 21% oxygen as the normoxic concentration.
We analyzed the mRNA expression for the core proteins of several secreted PG after 24 h exposure to hypoxia, and significant upregulation was seen for versican (40 fold ± 22, mean ± SEM of n = 12, P < 0.001) and perlecan (3.4 fold ± 0.7, mean ± SEM of n = 11, P = 0.007). Hypoxia did not increase the mRNA expression of serglycin or MCSF and no expression of decorin or biglycan was detected under either normoxic or hypoxic conditions (data not shown).
Western blots of HMDM lysates after 24 h normoxic and hypoxic incubations showed proteins reacting with a versican antibody with apparent molecular weights of ∼370, ∼260, ∼180, ∼130, and ∼98 kDa ( Figure 3A) . The 370 kDa band was consistently the most abundant isoform but we did not observe any differences in the content of the individual isoforms between normoxia and hypoxia (supplemental data table 1). Western blots of HMDM lysates with perlecan antibodies identified one main band for perlecan at ∼400 kDa and two small bands at ∼200 kDa and ∼150 kDa under both normoxic and hypoxic conditions ( Figure 3B ). In an attempt to directly quantify hypoxia-induced changes in versican protein levels, we pre-exposed HMDM to hypoxia or normoxia for 24 h and then incubated the cells with [
35 S]-methionine for 4 h in order to label the core proteins synthesized after the exposure to 24 h of hypoxia or normoxia. We analyzed the signal from the versican core protein in cell lysates in an immunoabsorbant assay with a specific antibody against the versican core protein. There were large variations between HMDM from different donors. Therefore, we were not able to draw any definite conclusions from [
35 S]-methionine experiments (data not shown).
To gain an indirect evaluation of the quantitative levels of versican produced by the cells, we labeled the PG-bound GAG chains using two different labels, [
35 S]-sulfate and Fig. 3 . Effects of hypoxia on versican protein synthesis in HMDM. Cells were incubated for 24 h under normoxic (21% O 2 ) or hypoxic (0.5% O 2 ) conditions and cell lysates were digested and separated by SDS-PAGE on 5% gels. One representative Western blot is shown for versican (A) and perlecan (B). The versican protein was indirectly evaluated by the radioactivity of its metabolically labeled GAG chains combined with immunoabsorption using a versican core protein antibody. Cells were preincubated for 24 h in hypoxia followed by 4 h labeling in hypoxia and compared with cells cultured under normoxic conditions. Versican-bound GAG chains were detected by [ 35 S]-sulfate and D-[6-3 H]-glucosamine hydrochloride (C) (mean ± SEM, n = 3). The signal obtained for each sample was normalized to cell protein.
[ 3 H]-glucosamine hydrochloride, and analyzed the radioactivity in cell lysates in the immunoabsorbant assay with the specific versican antibody. The results in Figure 3C show that the radioactivity from [ 35 S]-sulfate labeled versican increased 3-fold and that of [ 3 H]-glucosamine hydrochloride 7-fold after exposure to hypoxia compared to cells incubated in normoxia. Cell viability was not reduced in cells exposed to hypoxia for 28 h analyzed by the trypan blue exclusion test (supplemental data figure 1).
Putative hypoxia response elements in the versican and perlecan genes
To investigate if hypoxia could potentially modify versican and perlecan gene expression through HIF activation, we screened genomic regions covering −8000 to 8000 bp around the transcription start sites of the versican and perlecan genes for the presence of evolutionarily conserved hypoxia response elements (HRE). One putative binding site was identified in each of the genes ( Figure 4 ) and both sites showed complete conservation across seven mammalian species.
Versican and perlecan expression in THP-1 cells is partly dependent on HIF
To investigate if HIF was involved in the hypoxia-induced increases in versican and perlecan, further experiments were performed in THP-1 cells because a stable transfection is difficult to achieve in primary macrophages. We confirmed the hypoxic induction of versican and perlecan in THP-1 cells, and then investigated the effect of HIF-1α and HIF-2α knockdown in these cells. We showed that transfection of THP-1 cells with siRNA for HIF-1α resulted in significant reductions in hypoxia-induced HIF-1α and GLUT-1 (positive control) mRNA ( Figure 5A ). We previously showed that the HIF-1α protein expression was also reduced in THP-1 cells transfected with HIF-1α siRNA (Asplund et al. 2009 ). Transfection with HIF-2α siRNA also significantly reduced hypoxia-induced HIF-2α mRNA expression ( Figure 5A ). The genes reported as positive controls for HIF-2α in other cells (EPO, SOD2, VEGF-R2, and MMP12) were only expressed at very low levels in THP-1 cells and thus could not be used as positive controls.
Transfection of THP-1 cells with HIF-1α siRNA significantly decreased the hypoxia-induced increase in versican and perlecan mRNA expression ( Figure 5B ), but the reduction was less than that observed for GLUT-1. Thus, versican and perlecan expression may only be partly regulated by HIF-1α. Transfection of THP-1 cells with HIF-2α siRNA significantly decreased the hypoxia-induced increase in versican but did not significantly reduce the hypoxia-induced increase in perlecan (Figure 5C ). Hypoxia-induced versican expression was further reduced when THP-1 cells were transfected with both HIF-1α and HIF-2α siRNA ( Figure 5C ).
Discussion
Here we showed that versican was present and co-localized with HIF-1α in macrophage-rich areas in human advanced carotid lesions. We also showed that the expression of versican and perlecan core proteins increased in HMDM in response to hypoxia. Furthermore, both HIF-1α and HIF-2α knockdown reduced versican mRNA expression in THP-1 cells, whereas perlecan mRNA expression was only reduced by HIF-1α knockdown.
We found that both versican and HIF-1α were present in macrophage-rich areas in advanced carotid lesions. Our data thus indicate that macrophages may be a major contributor of versican core protein synthesis in hypoxic areas of advanced atherosclerotic lesions. We used 21% O 2 as the "normoxic" control concentration in our experiments because this concentration is used in the majority of published cell culture experiments. Although it is higher than the concentrations present in normal arterial intima (2.5-9% oxygen), we showed that the mRNA expression of versican and perlecan core proteins was similar at oxygen concentrations ranging from 21% to 2% and we only observed a pronounced increase in expression when the oxygen concentration was reduced to 0.5%.
Our data showing (1) the presence of versican in macrophagerich areas of human carotid lesions and (2) hypoxia-induced increases in versican expression in HMDM are consistent with a recent study in atherosclerotic mice indicating that macrophages may play an important role in versican accumulation in lesions (Seidelmann et al. 2008) . Our results are consistent with and extend earlier observations that showed versican mRNA expression in monocytes from a rat model of myocardial ischemia (Toeda et al. 2005) and in chronic ischemic myocardium in humans ). Furthermore, versican expression is induced in stem cells exposed to hypoxia, suggesting a role for versican in tissue engineering during chondrogenesis (Khan et al. 2007 ).
Our results indicating that hypoxia promotes perlecan expression are in contrast to a study in endothelial cells where hypoxia decreased perlecan expression (Li et al. 2007 ) and a recent study reported reduced perlecan expression in human atherosclerotic lesions (Tran et al. 2007 ). However, there is little information on this PG and further studies are required before the role of perlecan in the development of atherosclerotic lesions can be established.
Using antibodies against two versican peptide sequences in HMDM lysates, we detected bands of ∼370, ∼260, ∼180 kDa, which correspond to the molecular weights described for the three known isoforms V0, V1, and V2, respectively (DoursZimmermann and Zimmermann 1994; Schmalfeldt et al. 1998 ). However, we also detected bands of ∼130 and ∼98 kDa, which do not entirely correspond to V3 (predicted size of ∼72 kDa) or cannot be described by incomplete splicing of V3 generating a ∼2 kDa larger versican protein product (Lemire et al. 1999) . These bands might be the proteolytic product of other versican isoforms but the nature and relative expression of versican isoforms have not been studied in HMDM. Perlecan antibodies detected an expected band at ∼400 kDa, and two smaller bands that might be proteolytic products (Miller et al. 1997 ).
These immunoblots did not show reproducible changes in versican or perlecan core protein synthesis in HMDM after 24 h exposure to hypoxia, and we therefore further investigated hypoxia-induced differences in protein expression by metabolically labeling the core protein and the GAG chains. We focused our efforts on versican because of the much greater increase in mRNA expression for the versican core protein in hypoxia. We measured versican synthesis in cell lysates upon [ 35 S]-methionine labeling of the core protein together with immunoabsorption with the versican core protein antibody but could not detect any versican changes in response to hypoxia due to high variability between donors. This could theoretically be explained by general catabolic effects induced by hypoxia that may lead to secondary effects on amino acid pool sizes. However, we observed hypoxia-induced increases in versican when measuring the signals from the versican-bound GAG chains labeled with [
35 S]-sulfate and D-[6-3 H]-glucosamine hydrochloride. This indirect evaluation of changes in the versican core protein might be affected by potential hypoxia-induced changes in sulfation and size of the GAG chains but it is difficult to accept that such effects can lead to a 3 to 7-fold increase in radioactivity incorporation. However, changes in the GAG biosynthesis rate driven by the increase in gene expression of enzymes involved in the polysaccharide chains and the core protein may be responsible. Our findings generate interesting questions that will require analysis of the hypoxic effects on GAG biosynthesis and other experimental designs such as pulse-chase experiments.
Hypoxia is an important factor in the atherosclerotic process (Sluimer and Daemen 2009) and the transcription factor HIF is a key mediator of the hypoxic response (for review see Semenza (2007) ). HIF-1α was recently showed to co-localize with hypoxia and macrophages in human advanced atherosclerosis (Sluimer et al. 2008) . We identified conserved putative binding sites for HIF-1α in the versican and perlecan promoter regions and investigated the potential involvement of HIF in the hypoxia-induced increases in PG expression. As it is known to be difficult to achieve a stable siRNA transfection within HMDM from different donors, we performed siRNA experiments in THP-1 cells and found that HIF-1α and HIF-2α knockdown reduced the hypoxia-induced increases in versican mRNA expression. The hypoxia-induced increase in perlecan mRNA expression was only reduced by HIF-1α knockdown. There are very few studies indicating the role for HIF in PG synthesis. HIF-1α has been shown to regulate the PG aggrecan and type II collagen synthesis in chondrocytes (Semenza 2001; Pfander et al. 2003) , and a correlation of hypoxic-induced expression of HIF-2α and versican has been noted in stem cells (Khan et al. 2007 ). HIF-1α regulates genes involved in the acute response to hypoxia whereas HIF-2α is involved in the more long-term adaptive response to hypoxia. However, this regulation is complex since HIF-1α and HIF-2α also have overlapping functions and can compensate for each other (for review see Lofstedt et al. (2007) and Shohet and Garcia (2007) ).
Our study is the first to show that hypoxia induces versican synthesis in macrophages. The metabolic mechanism behind macrophages response to hypoxia and its relevance to atherosclerosis remain to be characterized in detail but hypoxic macrophages have been shown to accumulate increased amounts of triglycerides (Bostrom et al. 2006) , probably by downregulation of the mitochondrial fatty acids beta oxidation present in this condition. Furthermore, our laboratory has shown that overexposure of arterial SMC to fatty acids upregulates the expression and production of versican and perlecan (RodriguezLee et al. 2005 (RodriguezLee et al. , 2007 . This effect of fatty acids in SMC appears to be mediated by the accumulation of di-acyl glycerol that stimulates the phosphorylation of several of the protein kinase C isoforms. We therefore speculate that an excess of intracellular fatty acids and acyl-glycerides in hypoxic macrophages may also stimulate PG expression. In summary, our results provide further evidence for a proatherogenic role of macrophages in atherosclerotic lesions, which may be of importance to understand the role of macrophages in vascular pathology.
Material and methods
Immunohistochemistry
Human carotid endarterectomies from three patients, with highgrade symptomatic carotid artery stenosis, included in the Göteborg Atheroma Study Group biobank (www.wlab.gu.se/ GASG) were analyzed with immunohistochemistry. The study protocol was approved by the regional ethics committee, and all subjects gave informed consent. The endarterectomies were fixed in formalin upon removal and paraffin embedded. Serial sections (4 μm) were exposed to an Antigen Retrival buffer (DIVA Decloaker, Biocare Medical, Concord, CA) and stained with primary antibodies against CD68 (mouse monoclonal antibodies, 1:500 dilution, Novocastra Laboratories, Newcastle, UK), smooth muscle-specific α-actin (SMA) (1:1500, Enzo Diagnostics, Farmingdale, NY), HIF-1α (1 mg/mL, Novous Biologicals, Littleton, CO), and versican (4.58 μg/mL). Incubations were performed overnight for CD68 and SMA and for 1 h for HIF-1α and versican in a humid chamber at 20
• C. Mouse IgG1 and rabbit immunoglobulin fraction were used as negative controls (DAKO, Glostrup, Denmark). HIF-1α was detected with a Ultra Vision AP Detection System (Thermo Scientific, Waltham, MA) and CD68 and versican were detected with a MACH 3 kit (Biocare Medical). Immune complexes were visualized with Vulcan Fast Red Chromogen kit 2 (Biocare Medical) or the LSAB system HRP kit (DAKO). Sections were scanned with a Mirax Scanner and analyzed with the Mirax Viewer Software (Carl Zeiss MicroImaging GmbH, Germany).
Macrophage preparations
HMDM were isolated and differentiated as previously described (Asplund et al. 2009 ). THP-1 cells were cultured as previously described (Asplund et al. 2009) .
Cell cultures at different oxygen concentrations
Macrophages were incubated under different concentrations of oxygen as previously described (Asplund et al. 2009 ). The viability of HMDM was analyzed with the trypan blue exclusion test after hypoxic incubation and compared with cells incubated under normal cell culture conditions. Cells did not detach upon incubation in hypoxia and pH of the cell culture media was not changed during 24 h of hypoxia compared with normal cell culture conditions.
qRT-PCR
Cells were harvested and quantitative real-time PCR was performed as previously described (Asplund et al. 2009 ).
Primer Express 1.5 (Applied Biosystems, Foster City, CA) and GenBank sequences were used to design the following primers and probes: versican (NM_004385): forward ACGATGTG TATTGTTATGTGGATCATCT, reverse AGCCTCCTCGAAG-GTGAATTTA, and probe (5 FAM) TGATGTGTTCCACCT CACTGTCCCCA (3 TAMRA); decorin (XM_045925): forward AAGGCCACTATCATCCTCCTTCT, reverse AAAGT-CAAATAAGCCTCTCTGTTGAAA, and probe (5 FAM) TTGCACAAGTTTCCTGGGCTGGACC (3 TAMRA); biglycan (NM_001711): forward GTCTCTGCTGGCCCTGAGC, reverse TCATGAATGGCCCATCGTC, and probe (5 FAM) CCCTGCCCTTTGAGCAGAGAGGC (3 TAMRA); perlecan (NM_005529): forward TGGCTGACAGCATCTCAGGA, reverse CGATGGAGCGAGTG AAATTCA, and probe (5 FAM) ACTTCCAGATGGTTTATTTCCGAGCCCTG (3 TAMRA); serglycin: TCGGCTTGTCCTGGCCTCTT/ GCTCTCTGCG TAGGATAACCTTGA and probe CCCTCATCCTGGTTCTG GAATCCTCAG; and MCSF: ACACCATGCGCTTCAGA GATAA/TCAAAGAGAGTTCCTGCAGCTG and probe ACCCCCAATGCCATCGCCATT. Primers and probes were optimized, and amplification product sizes were estimated by standard PCR and electrophoresis. Primers and the probe for the versican core protein mRNA were selected from a region common to all isoforms (Lemire et al. 1999) . Assays on demand primers and probes: HIF-1α (Hs00153153_m1), HIF-2α also known as EPAS-1(Hs01026149_m1), GLUT-1 (Hs00197884_m1), EPO (Hs01071097_m1), SOD2 (Hs00167309_m1) VEGF-R2 (Hs00911700_m1), and MMP-12 (Hs00899662_m1). mRNA expression for all samples was normalized to β-actin levels (Nr. 4310881E).
Versican and perlecan antibodies
Individual rabbits were immunized with two peptide sequences of the versican core protein (NP_004376) 63-77 Ac-RIKWSKIEVDKNGKD (-C) and 2160-2174 Ac-TKKTYSDDKEMKEED (-C) and perlecan (NP_005520) 99-113 Ac-QLEDAGSREFREVSE (-C) and 4021-4035 Ac-ERLNKDGSLRVNGGR (-C). Antibodies were IgG purified and the binding of peptides to their antibodies was evaluated by ELISA.
Western blot
Western blots were performed after hydrolysis of the GAG by adding 5 mU/mL chondroitinase ABC and 50 mU of heparitinase III (Seikagaku, Tokyo, Japan) at 37
• C for ∼18 h. Samples (∼15 μg) were denatured in the buffer containing dithiothreitol and SDS and separated by SDS-PAGE with 5% gels (Bio-Rad, Hercules, CA). Proteins were transferred to a nitrocellulose membrane and exposed to antibodies in TBS containing 50 mg/mL milk and 0.1% Tween 20. Protein bands were visualized with the ECL detection kit and developed on hyperfilm. To check that all the immunoreactive bands detected by the antibodies contained versican and perlecan sequences, immunodetection reactions were run in an excess of the peptide antigen (versican 1:10 and perlecan 1:50). All bands were below detection limits, confirming that these bands contained the immunogenic sequence.
PG biolabeling
To label the PG, HMDM were incubated for 23 h under hypoxic or normal cell culture conditions in RPMI 1640 supplemented with 100 U/mL penicillin, 2 mM L-glutamine, 1× nonessential amino acids, 2 mM sodium pyruvate, and 0.1% sodium bicarbonate. Cells were washed with RPMI 1640 modified without methionine and cystine (Sigma-Aldrich, St. Louis, MO) (for PG core protein labeling) or sulfate-depleted MEM (Invitrogen Life Technologies, Carlsbad, CA) (for GAG labeling) followed by 1 h pre-incubation in respective medium. Cells were labeled with 50 μCi/mL (Asplund et al. 2009 ) for 4 h under hypoxic and normal cell culture conditions. For cells incubated in hypoxia, these procedures were carried out in the hypoxic chamber with hypoxic medium. Cells were harvested as described (Asplund et al. 2009 ).
Immunosorbent assay
The versican protein in cell lysates was determined by an immunosorbent assay. For detection of [
35 S]-methionine-labeled versican in cell lysates, [
35 S]-methionine-labeled samples were filtrated through centricon YM 3 in to a buffer containing 100 nM Tris, 10 mM EDTA, 10 μM CaCl 2 , pH 7.3. GAG chains were cleaved with 10 mU/mL chondroitinase ABC (Seikagaku) and 2 U/mL heparinase I and III (Sigma-Aldrich) at 37
• C for ∼18 h. Polysorb 96-well NUNC plates (Fisher Scientific, Roskilde, Denmark) were coated with a versican antibody 1:50 overnight at room temperature and washed three times with 0.05% Tween 20 in PBS. Fifty microliters of samples was applied in triplicates and the plate was incubated for 2 h at room temperature. Plates were washed four times with 0.05% Tween 20 in PBS, and scintillation liquid was added to each well before measuring [
35 S] in a microbeta counter. For detection of versican through its [
35 S]-sulfate and D-[6-3 H]-glucosamine hydrochloride-labeled GAG chains, Maxisorb 96-well NUNC plates (Fisher Scientific, Hanover Park, IL) were coated with the versican antibody 1:150 overnight at room temperature. Plates were washed three times with 0.05% Tween 20 in PBS and blocked with 1% BSA or ultra block (ready to use, AbD Serotec Düsseldorf, Germany) in room temperature for 1 h. Plates were washed three times with 0.05% Tween 20 and 100 μL of cell lysates was added in triplicates and incubated for 2 h at room temperature. Plates were washed four times and the radioactivity was measured in a microbeta counter. As controls, each sample was applied on a PBS-coated well. CPM values were normalized to protein concentrations determined with BCA protein assay kits (Pierce, Rockford, IL).
Sequence analysis
The UCSC browser multiz track (Kent et al. 2002; Blanchette et al. 2004 ) was used to obtain multiple sequence alignments, including human, chimpanzee, macaque, mouse, rat, cow, and dog, for regions covering −8000 to +8000 bp relative to the RefSeq annotated transcription start sites of the human versican and perlecan genes. A proprietary Matlab (Mathworks, Inc.) script was used to screen for evolutionarily conserved instances of the ACGTG core HRE motif (Wenger et al. 2005 ) on both strands.
siRNA targeting of HIF siRNA transfection of THP-1 monocytes with HIF-1α and HIF-2α (Ambion, Cambridgeshire, UK) was performed as previously described (Asplund et al. 2009 ).
Data analysis
Values are presented as mean ± SEM. Differences were evaluated with Student's paired t-tests, when normal distribution was obtained, or with Wilcoxon's sign rank test. P < 0.05 was considered statistically significant.
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